
Genky DrugStores (9267) Earnings: Operating Income Up 13.7% YoY to 10.98 Billion Yen, Net Income Increases 11.4%
StockClub
Published: Jul 28, 2026, 07:34 AM
Sentiment Analysis
Genky DrugStores (9267) announced its financial results, reporting operating income of 10,985 million yen, a 13.7% increase year-over-year. Net sales were 220,638 million yen (a 9.9% increase year-over-year), ordinary income was 11,157 million yen (a 12.7% increase), and net income attributable to owners of the parent was 7,875 million yen (an 11.4% increase). The operating profit margin stood at 5.0%.
From a financial and cash flow perspective, operating cash flow remained robust at 16,975 million yen, demonstrating strong cash-generating capabilities from core operations. Investing cash flow registered a negative 20,278 million yen due to active capital expenditures, resulting in a negative free cash flow of 3.30 billion yen while continuing aggressive business expansion. Furthermore, the return on equity (ROE) reached 13.8% (12.88% based on financial metrics) and the return on assets (ROA) recorded 5.41%, maintaining high profitability. Combined with cash and cash equivalents of 7.87 billion yen, the company sustains a solid financial foundation balancing stability and capital efficiency.
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.